About Walnut Life Sciences Private Limited
Data last updated:
Walnut Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 May 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2014PTC255336. Its GSTIN is 27AABCW5280A1ZJ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anil Mehnga Nijhawan and Kiran Anil Nijhawan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.86 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹67.75 Lakh (net margin 13.9%) and EBITDA of ₹94.76 Lakh (EBITDA margin 19.5%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 8% over five years.
The company has about 11 employees on its provident fund (EPFO) records.
Court records list 1 case involving the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website walnutlife.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressUnit No. 305 & 306 6th Floor The Platina Tanvi Complex, Near Dahisar Petrol Pump S V Road Dahisar (E), Mumbai, Maharashtra, India – 400068
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Walnut Life Sciences Private Limited
The main business activity of Walnut Life Sciences is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Walnut Life Sciences Private Limited FY 2025 filings available
Walnut Life Sciences Private Limited reported revenue of ₹4.86 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Walnut Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 3% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Walnut Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹94.76 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹67.75 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Walnut Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 13.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Walnut Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Walnut Life Sciences Private Limited
Walnut Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vexta Laboratories Private Limited | ₹4.89 Cr (FY 2019) | •••• | •••• | -21.0% | •••• | Mummbai, Maharashtra, India |
| Hibrow Healthcare Private Limited | ₹4.89 Cr (FY 2024) | •••• | •••• | -32.0% | •••• | Uthiramerur, Tamil Nadu, India |
| Genericare Pharmacy Private Limited | ₹4.88 Cr (FY 2024) | •••• | •••• | 26.0% | •••• | Nashik, Maharashtra, India |
| Atlas Biosciences Private Limited | ₹4.88 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Pune, Maharashtra, India |
| Refex Life Sciences Private Limited | ₹4.86 Cr (FY 2025) | •••• | •••• | 146.0% | •••• | Chennai, Tamil Nadu, India |
| Walnut Life Sciences Private Limited this company | ₹4.86 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Mumbai, Maharashtra, India |
| Lotuspharm Manufacturing Private Limited | ₹4.86 Cr (FY 2025) | •••• | •••• | 208.0% | •••• | Delhi, India |
| Allen's India Ltd. | ₹4.86 Cr (FY 2024) | •••• | •••• | 1.0% | •••• | Kolkata, West Bengal, India |
| Uniphar Biotech Private Limited | ₹4.85 Cr (FY 2024) | •••• | •••• | -9.0% | •••• | Chandigarh, India |
| Villmed Laboratories Private Limited | ₹4.85 Cr (FY 2024) | •••• | •••• | 112.0% | •••• | Selaqui, Uttarakhand, India |
| Transcure Therapeutics Private Limited | ₹4.85 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Ludhiana, Punjab, India |
Peers are the five companies nearest above and the five nearest below Walnut Life Sciences by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Walnut Life Sciences Private Limited
Walnut Life Sciences Private Limited is audited by GONDALIYA AND ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GONDALIYA AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Walnut Life Sciences Private Limited
Walnut Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Mehnga Nijhawan | Director | 02 Jun 2016 | 10 Years 4 Months | Current |
| Kiran Anil Nijhawan | Director | 30 May 2014 | 12 Years 4 Months | Current |
Ownership and Shareholding of Walnut Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Walnut Life Sciences Private Limited
Walnut Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Walnut Life Sciences Private Limited
Walnut Life Sciences Private Limited has 1 court case on record: 1 where it is another party. All case is pending. Status as checked on 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons warrant cases SW) | Company is another party | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Walnut Life Sciences Private Limited
Walnut Life Sciences Private Limited has a workforce of 11 employees as of Mar 22, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Walnut Life Sciences Private Limited
Walnut Life Sciences Private Limited has 4 board changes on record since 2014: 3 appointments and 1 cessation. The latest: Anil Mehnga Nijhawan was appointed as Director on 02 Jun 2016.
Credit Ratings, Litigation & Regulatory Alerts for Walnut Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Walnut Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Walnut Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Walnut Life Sciences Private Limited
Walnut Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCW5280A1ZJ | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Walnut Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Walnut Life Sciences Private Limited
Walnut Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 May 2014 (12+ years old) and is registered under CIN U24110MH2014PTC255336.
Walnut Life Sciences reported revenue of ₹4.86 Cr for FY 2025 (up 3% YoY).
Walnut Life Sciences has 2 current directors:
- Anil Mehnga Nijhawan - Director
- Kiran Anil Nijhawan - Director
Walnut Life Sciences reported a net profit of ₹67.75 Lakh (net margin 13.9%) and EBITDA of ₹94.76 Lakh (EBITDA margin 19.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Walnut Life Sciences is 11% over three years and 8% over five years. In the latest year (FY 2025) revenue rose 3%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Walnut Life Sciences is 27AABCW5280A1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Walnut Life Sciences is U24110MH2014PTC255336. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Walnut Life Sciences has 1 court case on record. 1 is pending.
Walnut Life Sciences was incorporated on 30 May 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Walnut Life Sciences by revenue are Vexta Laboratories Private Limited, Hibrow Healthcare Private Limited, Genericare Pharmacy Private Limited, Atlas Biosciences Private Limited, Refex Life Sciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Anil Mehnga Nijhawan was appointed as Director on 02 Jun 2016. Durga Venkata Ratnam Modukuri ceased to be Director on 02 Jun 2016. Durga Venkata Ratnam Modukuri was appointed as Director on 30 May 2014. Walnut Life Sciences has 4 board changes on record in total.